Drug Abuse Testing Market By Product and Service (Analyzers, Rapid Testing Devices, Consumables, Laboratory Services) , By Sample type (Urine, Oral Fluid, Breath, Hair, Other Samples) By End User (Workplaces and Schools, Criminal Justice Systems and Law E

Drug Abuse Testing Market By Product and Service (Analyzers, Rapid Testing Devices, Consumables, Laboratory Services) , By Sample type (Urine, Oral Fluid, Breath, Hair, Other Samples) By End User (Workplaces and Schools, Criminal Justice Systems and Law Enforcement Agencies, Research laboratories, Hospitals) : Global Opportunity Analysis and Industry Forecast, 2024-2033

The drug abuse testing market was valued at $5.0 million in 2023, and is projected to reach $8.8 million by 2033, growing at a CAGR of 6% from 2024 to 2033.

Drug abuse testing refers to the scientific process of identifying the presence of illicit drugs, prescription medications, or their metabolites in a person's system. This testing is conducted using biological specimens such as urine, blood, saliva, hair, or sweat to determine if an individual has used specific substances. Drug abuse testing is a critical tool in workplace safety, clinical diagnostics, legal investigations, and rehabilitation programs.

Alarming increase in prevalence of substance abuse disorders worldwide is a primary driver of the drug abuse testing market. According to a report by the United Nations Office on Drugs and Crime (UNODC), over 284 million people aged 15–64 used drugs at least once in 2022, underscoring the need for widespread testing. In addition, rise in awareness about the impact of substance abuse on public safety, such as impaired driving and drug-related crimes, has driven the demand for routine drug testing in law enforcement and traffic monitoring programs. Moreover, increase in global drug availability significantly contributes toward the market growth. For instance, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported in 2024 that Europe is experiencing unprecedented availability of various drugs, with cannabis being the most commonly used illicit drug, followed by cocaine. Furthermore, the availability of cost-effective and easy-to-use home drug testing kits has seen increased adoption among individuals and families, contributing to market expansion. However, sophisticated drug testing techniques, such as liquid chromatography-mass spectrometry, are expensive. This can limit their adoption, especially in resource-constrained healthcare settings. Fear of societal judgment and discrimination may deter individuals from undergoing drug testing voluntarily, further affecting the growth of testing programs. On the contrary, technological innovations, such as point-of-care testing devices, improved immunoassays, and mass spectrometry techniques, have made drug testing more accurate, faster, and accessible. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The drug abuse testing market is segmented into product & service, sample type, end user, and region. By product & service, the market is divided into analyzers, rapid testing devices, consumables and laboratory services. The analyzers segment is further segmented into immunoassay analyzers, chromatography analyzers and breath analyzers. The rapid testing devices is subdivided into urine testing devices and oral fluid testing devices. The consumables segment is further categorized into assay kits, sample collection cups, calibrators & controls, and others. Depending on sample type, the market is segregated into urine, oral fluid, breath, hair, and other samples. By end user, it is fragmented into workplaces & schools, criminal justice systems & law enforcement agencies, research laboratories, and hospitals. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product & service, the analyzers segment dominated the market share in 2023.

On the basis of sample type, the urine segment exhibit the highest growth in 2023.

Depending on end user segment, the workplaces & schools segment garnered the largest share in 2023.

Region wise, North America held the largest market share in 2023, and is projected to grow at a high pace during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global drug abuse testing market include The Drägerwerk AG & Co. KGaA, Abbott Laboratories, F. HOFFMANN-LA ROCHE AG, Bio Rad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Danaher Corporation, Quest Diagnostics Incorporated, and Express Diagnostics International Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Key Market Segments

By Product And Service

Analyzers
Immunoassay analyzers
Chromatography analyzers
Breath analyzers
Rapid Testing Devices
Urine testing devices
Oral fluid testing devices
Consumables
Assay kits
Sample collection cups
Calibrators and controls
Others
Laboratory Services

By Sample Type

Urine
Oral Fluid
Breath
Hair
Other Samples

By End User

Workplaces and Schools
Criminal Justice Systems and Law Enforcement Agencies
Research laboratories
Hospitals

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA

Key Market Players

The Drägerwerk AG & Co. KGaA
Abbott Laboratories
F. HOFFMANN-LA ROCHE AG
Bio Rad Laboratories, Inc.
Siemens AG
Thermo Fisher Scientific, Inc.
Laboratory Corporation of America Holdings
Danaher Corporation
Quest Diagnostics Incorporated
Express Diagnostics International Inc.